Screener
Capricor Therapeutics CAPR Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| REVENUE / TOTAL REVENUE | Three Months Ended March 31, 2026 / — | Three Months Ended March 31, 2025 / — |
|---|---|---|
| OPERATING EXPENSES | ||
| Research and development | 27,376,912 | 18,915,572 |
| General and administrative | 9,395,941 | 6,067,376 |
| TOTAL OPERATING EXPENSES | 36,772,853 | 24,982,948 |
| LOSS FROM OPERATIONS | (36,772,853) | (24,982,948) |
| OTHER INCOME (EXPENSE) | ||
| Other income | 8,145 | 12,485 |
| Investment income | 2,904,506 | 729,542 |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's total operating expenses?
- Capricor Therapeutics (CAPR) reported total operating expenses of $36.77M in Q1 2026.
- How has Capricor Therapeutics's total operating expenses changed year-over-year?
- Capricor Therapeutics's total operating expenses increased by 47.2% year-over-year, from $24.98M to $36.77M.
- What is the long-term trend for Capricor Therapeutics's total operating expenses?
- Over 4 years (2021 to 2025), Capricor Therapeutics's total operating expenses has grown at a 50.3% compound annual growth rate (CAGR), from $21.18M to $108.14M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.
Ask your AI about Capricor Therapeutics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude